Application of Rhus chinensis fruit extract in preparing medicine for preventing and treating uric acid nephropathy
Through the extract of ethanol aqueous solution of salt-skin wood fruit, the high cost and side effects of existing drugs for treating uricidal nephropathy are solved, and the effect of effectively preventing and improving uricidal nephropathy is achieved, which significantly reduces the oxidative stress and inflammatory response of renal tissues is achieved. , provides safe and efficient prevention and control solutions.
Patent Information
- Application Number
- CN202210126236.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-02-10
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2042-02-10
AI Technical Summary
The existing drugs for treating uric acid nephropathy caused by hyperuricemia have high costs and serious side effects, and lack natural and side effects prevention and treatment methods.
It is prepared by ultrasonic extraction, concentration and freeze-drying as a drug or functional food for preventing and treating uricidal nephropathy.
Salt-skin fruit extract effectively prevents and improves uric acid nephropathy induced by potassium oxazineate at low doses, significantly reduces oxidative stress and inflammatory responses in renal tissues, protects renal function, and is safe and highly crafted Simple.
Smart Images

Figure CN116617280B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of medicines, and in particular relates to application of a Rhus chinensis fruit extract in preparing medicines for preventing and treating uric acid nephropathy. Background Art
[0002] Uric acid is the end product of purine metabolism in the human body. Excessive production and reduced excretion can increase blood uric acid. Studies have shown that three-quarters of uric acid in the body is excreted by the kidneys, but when the blood uric acid level is too high, sodium urate crystals are deposited in the renal medulla or interstitium, causing uric acid nephropathy, kidney stones, etc., and even leading to death, seriously affecting the quality of life and people's health. According to statistics, 30% of patients with primary hyperuricemia have varying degrees of kidney damage. At present, the clinical treatment of uric acid nephropathy caused by hyperuricemia mainly uses some drugs that inhibit uric acid production and promote uric acid excretion, such as allopurinol, febuxostat and benzbromarone. These drugs are not only expensive but also often have side effects such as gastrointestinal reactions, rashes and liver and kidney damage. Therefore, it is very necessary and meaningful to develop some low-cost and side-effect-free natural product raw materials from natural edible plant raw materials to prevent and treat uric acid nephropathy.
[0003] Rhus chinensis Mill. is a species of the genus Rhus of the Anacardiaceae family. Its fruit is often used as a natural source of beverages, spices and edible fruit oils. It is a valuable economic tree and is widely distributed. Currently, there is no report on the ability of Rhus chinensis Mill. fruit extract to prevent, treat or improve uric acid nephropathy. Summary of the invention
[0004] In view of this, the object of the present invention is to provide an application of a Rhus chinensis fruit extract in the preparation of a drug for preventing and treating uric acid nephropathy. The present invention uses a uric acid nephropathy model induced by a high-purine diet plus potassium oxonate to find that Rhus chinensis fruit can effectively prevent and improve uric acid nephropathy induced by a high-purine diet plus potassium oxonate. The present invention provides a new use for further developing and utilizing the Rhus chinensis fruit extract.
[0005] The invention provides application of a Rhus chinensis fruit extract in preparing a medicine for preventing and treating uric acid nephropathy.
[0006] Preferably, the Rhus chinensis fruit extract is an ethanol aqueous solution extract of Rhus chinensis fruit.
[0007] Preferably, the method for preparing the Rhus chinensis fruit extract comprises the following steps: mixing the Rhus chinensis fruit with an ethanol aqueous solution, performing ultrasonic extraction, collecting the filtrate, concentrating it, and freeze-drying it.
[0008] Preferably, the mass concentration of the ethanol aqueous solution is 75% to 85%.
[0009] Preferably, the mass volume ratio of the Rhus chinensis fruit to the ethanol aqueous solution is 1 g: (3-8) ml.
[0010] Preferably, the temperature of the ultrasonic extraction is 23-27° C., the number of ultrasonic extractions is 1-3 times, the time of each ultrasonic extraction is 25-35 minutes, and the power of the ultrasonic extraction is 150-250W.
[0011] Preferably, the drug is an oral preparation.
[0012] The invention also provides the use of the Rhus chinensis fruit extract in preparing functional food for preventing and treating uric acid nephropathy.
[0013] Compared with the prior art, the present invention has the following beneficial effects: the present invention has discovered new functional foods or medical uses for Rhus chinensis fruit, and has opened up a new research field for Rhus chinensis fruit; the present invention has found through experiments that the 80% ethanol aqueous solution extract of Rhus chinensis fruit can effectively prevent and improve uric acid nephropathy at a lower dose, and the extract comes from edible natural plant raw materials and has high safety. Further, Rhus chinensis plants can adapt to various harsh natural environments, are widely distributed in my country, and are easily available in daily life; and traditionally, Rhus chinensis fruit is an edible seasoning, and Rhus chinensis fruit oil is a new food raw material with high safety; the extraction and preparation process is simple, the market prospect is considerable, and it contains good social and economic effects. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] Figure 1 The figure shows the morphology of kidney tissue and HE staining results of mice with high uric acid levels; A is a visual image of mouse kidney tissue; C in A is the control group; M is the model group; P is the positive group (5 mg / kg bw allopurinol); YL is the low-dose group (400 mg / kg bw sample); YH is the high-dose group (800 mg / kg bw sample); Figure 1 B and C in the figure are the results of HE-stained sections of kidney tissue photographed at 100 times and 200 times respectively;
[0015] Figure 2 The effect of Rhus chinensis fruit extract on plasma creatinine (Cr), urine creatinine (Cr), plasma urea nitrogen (BUN), plasma uric acid (UA), urine uric acid (UA) and urine acetylglucosaminidase (NAG) in mice fed with high-purine yeast diet and induced by potassium oxonate; All values are expressed as mean ± SE (n = 10); Different letters in the same bar graph indicate significant differences (p < 0.05); C is the control group; M is the model group; P is the positive group (5 mg / kg bw allopurinol); YL is the low-dose group (400 mg / kg bw sample) and YH is the high-dose group (800 mg / kg bw sample);
[0016] Figure 3 The effect of Rhus chinensis fruit extract on the levels of SOD, GSH and MDA in the kidney of mice induced by high-purine yeast diet and potassium oxonate; all values are expressed as mean ± SE (n = 10); different letters in the same bar graph indicate significant differences (p < 0.05); SOD is superoxide dismutase; GSH is glutathione; MDA is malondialdehyde; C is the control group; M is the model group; P is the positive group (5 mg / kg bw allopurinol); YL is the low-dose group (400 mg / kg bw sample) and YH is the high-dose group (800 mg / kg b.w sample);
[0017] Figure 4 A in the figure is the effect of 80% ethanol aqueous solution extract of Rhus chinensis fruit on the plasma IL-1β level of mice induced by high-purine yeast diet and potassium oxonate; Figure 4 B in the figure shows the effect of 80% ethanol aqueous solution extract of Rhus chinensis fruit on IL-6 level in plasma of mice induced by high-purine yeast diet plus potassium oxonate; all values are expressed as mean ± SE (n = 10); different letters in the same bar graph indicate significant differences (p < 0.05); IL-1β is interleukin (IL) 1β; IL-6 is interleukin 6; TNF-α is tumor necrosis factor α; C is control group; M is model group; P is positive group (5 mg / kg bw allopurinol); YL is low-dose group (400 mg / kg bw sample) and YH is high-dose group (800 mg / kg bw sample). DETAILED DESCRIPTION
[0018] The invention provides application of a Rhus chinensis fruit extract in preparing a medicine for preventing and treating uric acid nephropathy.
[0019] In the present invention, the Rhus chinensis fruit extract is obtained by extracting Rhus chinensis fruit as raw material; in the present invention, the Rhus chinensis fruit extract is preferably an ethanol aqueous solution extract of Rhus chinensis fruit, more preferably an extract of 75% to 85% ethanol aqueous solution.
[0020] In the present invention, the method for preparing the Rhus chinensis fruit extract preferably comprises the following steps: mixing the Rhus chinensis fruit with an ethanol aqueous solution, ultrasonically extracting, collecting the filtrate, concentrating, and freeze-drying.
[0021] In the present invention, first, the Rhus chinensis fruit is mixed with an ethanol aqueous solution and ultrasonically extracted. In the present invention, the mass concentration of the ethanol aqueous solution is preferably 75% to 85%, more preferably 78 to 82%, and more preferably 80%. The present invention has no special restrictions on the source of the Rhus chinensis fruit, and the Rhus chinensis fruit dried from conventional sources in the art can be used. Before the Rhus chinensis fruit is mixed with the ethanol aqueous solution, the dried Rhus chinensis fruit is crushed and sieved to collect the undersize components. The present invention has no special restrictions on the crushing method, and the conventional crushing method in the art can be used. The mesh size of the sieved sieve is preferably 40-60 meshes. In the present invention, the mass volume ratio of the Rhus chinensis fruit to the ethanol aqueous solution is preferably 1g: (3 to 8) ml, more preferably 1g: (4 to 6) ml, and more preferably 1g: 5ml. In the present invention, the temperature of the ultrasonic extraction is preferably 23-27°C, more preferably 24-26°C, and more preferably 25°C; the number of ultrasonic extractions is preferably 1-3 times, and more preferably 2 times; the time of each ultrasonic extraction is preferably 25-35 minutes, and more preferably 28-32 minutes, and more preferably 30 minutes; the power of the ultrasonic extraction is preferably 150-250W, and more preferably 200W. In the present invention, the second or third extraction is an extraction performed by mixing the filter residue after the first extraction as a raw material with an ethanol aqueous solution.
[0022] The present invention collects the filtrate after the ultrasonic extraction is completed; the method of collecting the filtrate is preferably filtration; in the present invention, the filtration is preferably performed by negative pressure filtration using a Buchner funnel filter paper; in the present invention, when the number of extractions is greater than 1, the collected filtrate preferably also includes merging the filtrates of multiple extractions after filtration.
[0023] After collecting the filtrate, the filtrate is concentrated and freeze-dried to obtain the Rhus chinensis fruit extract. In the present invention, the concentration method is preferably evaporation and concentration at 45°C using a rotary evaporator, and the concentration multiple is preferably 5 times; the freeze-drying temperature is preferably -60 to -50°C, more preferably -56°C, and the freeze-drying time is preferably 46 to 52 hours, more preferably 48 hours.
[0024] The present invention also provides the use of Rhus chinensis fruit extract in the preparation of functional food for preventing and treating uric acid nephropathy. The present invention does not specifically limit the type of the functional food, and the functional food includes the Rhus chinensis fruit extract and its food-acceptable excipients, and the excipients are preferably one or more of mannitol, povidone, magnesium stearate, compressible starch and β-cyclodextrin. In the present invention, the mass percentage of mannitol in the functional food is preferably 10% to 15%, the mass percentage of povidone in the functional food is preferably 3% to 5%, and more preferably 4%; the mass percentage of magnesium stearate in the functional food is preferably 0.1% to 1%, the mass percentage of compressible starch in the functional food is preferably 10% to 15%, and more preferably 11% to 14%, and the mass percentage of β-cyclodextrin in the functional food is preferably 5% to 10%, and more preferably 6% to 9%.
[0025] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.
[0026] Example 1
[0027] Preparation of 80% ethanol aqueous solution extract of Rhus chinensis fruit
[0028] The specific method is as follows: 1L of 80% ethanol aqueous solution is mixed with 200g of Rhus chinensis fruit for ultrasonic extraction; the extraction temperature is 25°C, the extraction time is 30min, and the ultrasonic power is 200W. After the first extraction, the filtrate and residue are collected by filtration, and the residue is mixed with 1L of 80% ethanol aqueous solution for re-extraction. The temperature, time and power of the re-extraction are kept consistent with those of the first extraction; after filtration, the filtrates of the two extractions are combined, and then frozen at -30°C and freeze-dried in a freeze dryer at a temperature of -52°C and a vacuum degree of <0.1Mpa for 48 hours to obtain the product.
[0029] Example 2
[0030] An example of uric acid nephropathy in mice induced by a high-purine diet plus potassium oxonate
[0031] A mouse model of uric acid nephropathy was established using a high-purine yeast feed combined with intraperitoneal injection of potassium oxonate. The preventive and therapeutic effects of an 80% ethanol aqueous solution extract of Rhus chinensis fruit on renal damage in hyperuricemia mice induced by a high-purine diet plus potassium oxonate were observed through animal model experiments.
[0032] Test materials
[0033] animal
[0034] Eight-week-old SPF male Kunming mice (20 g to 22 g) were purchased from Hunan Slake Jingda Experimental Animal Co., Ltd.
[0035] Preparation of 80% ethanol aqueous solution extract of Rhus chinensis fruit
[0036] The preparation method of the 80% ethanol aqueous solution extract of Rhus chinensis fruit is described in Example 1.
[0037] Modeling and testing
[0038] All Kunming male mice were SPF mice weighing 20-22 g. Before the experiment, 50 mice were randomly divided into 5 groups, 10 mice in each group, namely: control group (C group), model group (M group), positive control group (P group), Rhus chinensis fruit low-dose group (YL group) and Rhus chinensis fruit high-dose group (YH group).
[0039] After the experiment started, except for group C which ate ordinary feed, all the other four groups of experimental mice ate feed with high purine yeast supplemented with 10% dry yeast powder and 0.1% adenine, and were gavaged every day. Groups C and M were gavaged with normal saline every day, group P was gavaged with allopurinol solution every day, the gavage dose was 5 mg / kg, group YL was gavaged with 80% ethanol aqueous solution extract of Rhus chinensis fruit every day, the gavage dose was 400 mg / kg, and group YH was gavaged with 80% ethanol aqueous solution extract of Rhus chinensis fruit every day, the gavage dose was 800 mg / kg. After 6 months, except for group C, the other four groups were intraperitoneally injected with potassium oxonate every day for 7 consecutive days. After 7 days, all mice were fasted but not water, and all mice were anesthetized and euthanized by cervical dislocation after collecting 24h urine. Blood was collected and centrifuged to collect plasma for subsequent index measurement. The kidney tissue of the mice was collected, rinsed with normal saline, and fixed with 4% paraformaldehyde for pathological section analysis.
[0040] Test results
[0041] Pathological analysis of the effects of 80% ethanol aqueous solution extract of Rhus chinensis fruit on kidney tissue of hyperuricemia mice
[0042] Figure 1The following are intuitive images and histopathological sections of the kidneys of mice induced by high-purine yeast feed and potassium oxonate. From the intuitive images of the kidneys, it can be seen that the kidneys of group C are plump, ruddy, and smooth, while the kidneys of group M are whitish, uneven on the surface, and have obvious granularity. The kidney tissues of groups P, YL, and YH are all ruddy in color compared to group M. Histopathological sections show that the histological structure of the glomeruli, renal cortex, and medullary tubules in group C is normal. The renal tissue of group M underwent significant structural changes, with dilated tubular lesions, tubular degeneration, and tubular interstitial atrophy. After pretreatment with allopurinol (group P) and samples (YL and YH), renal tissue lesions were significantly improved, and the tissue structure was significantly improved. Among them, the dilation of renal tubular lesions in groups P and YH was significantly reduced, and interstitial atrophy was significantly improved. In particular, no obvious tissue damage was observed in the YH group. There were still lesions in the renal tissue of group YL, but there was also significant improvement compared to the renal tissue of group M. This shows that Rhus chinensis fruit is indeed effective in preventing and treating renal damage in mice induced by a high-purine diet and potassium oxonate.
[0043] Effects of 80% ethanol aqueous solution extract of Rhus chinensis fruit on biochemical parameters of kidney tissue in mice with hyperuricemia
[0044] Uric acid is a metabolite of purine nucleotides in the body. Almost three-quarters of uric acid is excreted in urine through the kidneys. Therefore, when uric acid in the blood increases, urate deposition in the kidneys can occur, causing chronic urate nephropathy and uric acid kidney stones. Serum creatinine is a metabolite of muscle creatine, and blood urea nitrogen is the end product of protein metabolism, but both are mainly excreted in urine through glomerular filtration. When the glomerular filtration function is damaged, creatinine and urea nitrogen in the blood cannot be excreted from the body through urine, resulting in increased levels of creatinine and urea nitrogen in the blood and decreased levels of creatinine in urine. Therefore, increased levels of blood creatinine and urea nitrogen and decreased levels of creatinine in urine are considered to be the main signs of damage to glomerular filtration function. And acetyl glucosidase is the most sensitive indicator of renal tubular function. It is most abundant in renal tubular epithelial cells. The increase in the level of acetyl glucosidase in urine can effectively reflect renal tubular damage. Figure 2The levels of plasma creatinine (Cr), urine Cr, plasma urea nitrogen (BUN), plasma uric acid (UA), urine UA and urine acetylglucosaminidase (NAG) in mice induced by high-purine yeast feed and potassium oxonate. It can be seen from the figure that the levels of plasma Cr, urine Cr, plasma BUN, plasma UA, urine UA and urine NAG in group M were significantly changed compared with group C (p < 0.05). After pretreatment with allopurinol (P group) and samples (YL group and YH group), these indicators were significantly improved (p < 0.05). Compared with the P group, there were no significant differences in plasma BUN and urine UA in the YL group and the YH group (p > 0.05), and urine Cr was significantly higher than that in the P group (p < 0.05), while there was no significant difference in plasma Cr between the YH group and the P group (p > 0.05). The plasma UA and urine NAG levels in the YH group were significantly lower than those in the P group (p < 0.05), and there was no significant difference in plasma Cr between the YH group and the C group (p > 0.05). Therefore, these results all indicate that the 80% ethanol aqueous solution extract of Rhus chinensis fruit can effectively prevent and alleviate renal damage caused by hyperuricemia.
[0045] Effects of 80% ethanol aqueous solution extract of Rhus chinensis fruit on antioxidant indexes in kidney tissue of mice with hyperuricemia
[0046] Figure 3 The levels of superoxide dismutase (SOD), glutathione (GSH) and malondialdehyde (MDA) in the kidney tissue of mice induced by high-purine yeast feed and potassium oxonate. It can be seen from the figure that the blood superoxide dismutase (SOD) and glutathione (GSH) in group M were significantly lower than those in group C, and the MDA level was significantly higher than that in group C (p < 0.05). The oxidative stress in the kidney tissue caused by high-purine yeast feed and potassium oxonate led to the reduction of antioxidant enzyme system and the production of lipid peroxidation MDA. The superoxide dismutase (SOD) and glutathione (GSH) in groups P, YL and YH were significantly higher than those in group M, and the MDA level was also significantly reduced. It shows that these indicators were significantly improved after pretreatment with allopurinol (group P) and sample (group YL and group YH) (p < 0.05). Therefore, these results indicate that the 80% ethanol aqueous solution extract of Rhus chinensis fruit can effectively reduce the oxidative stress response caused by high uric acid and reduce renal function damage.
[0047] Effects of 80% ethanol aqueous solution extract of Rhus chinensis fruit on inflammatory factors in plasma of mice with hyperuricemia
[0048] Figure 4The levels of inflammatory factors IL-1β and IL-6 in the plasma of mice induced by high-purine yeast feed and potassium oxonate. As can be seen from the figure: the levels of IL-1β and IL-6 in group M were significantly higher than those in group C (p < 0.05). This indicates that an inflammatory response occurred in the body, which may be caused by the increase in uric acid caused by hyperuricemia. The levels of IL-1β and IL-6 in groups P, YL and YH were significantly reduced. This shows that the salt bran extract can significantly reduce the body's inflammatory response. Therefore, these results indicate that the 80% ethanol aqueous solution extract of Rhus chinensis fruit may be able to effectively reduce the inflammatory response caused by hyperuricemia, thereby preventing and improving renal damage caused by hyperuricemia.
[0049] From the above examples, it can be seen that the Rhus chinensis fruit extract provided by the present invention can effectively prevent and treat uric acid nephropathy and protect renal function from damage caused by high uric acid, which may be due to the fact that the Rhus chinensis fruit extract significantly reduces the oxidative stress and inflammatory response of renal tissue. Therefore, the Rhus chinensis fruit extract can be used to develop drugs or functional foods for preventing and treating uric acid nephropathy.
[0050] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. The use of Rhus chinensis fruit extract in the preparation of a medicament for preventing and treating uric acid nephropathy, characterized in that: The Rhus chinensis fruit extract is an ethanol aqueous solution extract of Rhus chinensis fruit; The preparation method of the Rhus chinensis fruit extract comprises the following steps: mixing the Rhus chinensis fruit with an ethanol aqueous solution, ultrasonically extracting, collecting the filtrate, concentrating, and freeze-drying; The volume concentration of the ethanol aqueous solution is 75% to 85%; The mass volume ratio of the Rhus chinensis fruit to the ethanol aqueous solution is 1 g: (3-8) ml; The temperature of the ultrasonic extraction is 23-27° C., the number of ultrasonic extractions is 1-3 times, the time of each ultrasonic extraction is 25-35 min, and the power of the ultrasonic extraction is 150-250 W; The medicine is an oral preparation.
